Salts of methyl (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl) -butyryl]-3-trifluoromethyl5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazi ne-1-carboxylate

Details for Australian Patent Application No. 2010252508 (hide)

Owner JIANGSU HENGRUI MEDICINE CO., LTD.

Inventors Yuan, Kaihong; Ma, Shuqin; Zhu, Lin; Liu, Huawen

Agent Griffith Hack

Pub. Number AU-A-2010252508

PCT Pub. Number WO2010/135944

Priority 200910145237.8 27.05.09 CN

Filing date 29 April 2010

Wipo publication date 2 December 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/135944 Priority application(s): WO2010/135944

7 June 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 May 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010252545-Re-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nanoencapsulated drug in human artery with body pH

2010252500-Method and apparatus for authentication in passive optical network and passive optical network thereof